ALESSANDRA WILLIAMSON: Open Payments
NPI 1831511955 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 23 payments from 10 companies in 2025. Trend: 2023 $400 · 2024 $658 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
| GENZYME CORPORATION | 4 | $102 |
| CSL Behring | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Ionis Pharmaceuticals, Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Cycle Pharmaceuticals Inc | 1 | $32 |
| Genentech USA, Inc. | 1 | $27 |
| BioCryst US Sales Co., LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: DUPIXENT, Haegarda, HYQVIA, Sajazir, DAWNZERA, Xolair, ORLADEYO, TAKHZYRO.
Industry payments across FL — which companies pay providers there.
